Suppr超能文献

中国患者使用Matrix可解脱弹簧圈治疗颅内动脉瘤的临床及血管造影结果

Clinical and angiographic outcome of intracranial aneurysms treated with Matrix detachable coils in Chinese patients.

作者信息

Wong George K C, Yu Simon C H, Poon W S

机构信息

Division of Neurosurgery, Prince of Wales Hospital, Chinese University of Hong Kong, China.

出版信息

Surg Neurol. 2007 Feb;67(2):122-6; discussion 126. doi: 10.1016/j.surneu.2006.05.063.

Abstract

BACKGROUND

Aneurysm recurrence is an innate problem in endovascular treatment of aneurysms with coils. A coated coil system named Matrix (Boston Scientific Neurovascular, Fremont, CA), covered with a bioabsorbable polymeric material (polyglycolide/lactide copolymer [PGLA]), was developed to accelerate intraaneurysmal clot organization and fibrosis. The purpose of this study was to evaluate the efficacy and safety of the Matrix detachable coils in patients with intracranial aneurysms and aneurysmal recurrence rate.

METHODS

In a regional neurosurgical center in Hong Kong, data of patients undergoing endovascular embolization of intracranial aneurysm was collected. In a 20-month period, 42 patients with 44 aneurysms were treated by endovascular embolization using matrix coils alone or mixed with bare platinum coils. Thirty-four patients presented with ruptured aneurysms, and 8 patients presented with unruptured aneurysms.

RESULTS

Twenty-five patients (60%) had 6-month follow-up DSA, and 10 patients (24%) had 18-month follow-up DSA. Seven aneurysm recurrences were identified, amounting to 16% for all aneurysms and 14% for ruptured aneurysms. Four patients were treated by repeated embolization, and 2 patients were treated by microsurgical clipping. Two adverse events due to thromboembolism were noted. One 78-year-old lady with poor-grade subarachnoid hemorrhage treated by partial embolization died from rebleed at day 4. Another patient with partial embolization and spontaneous thrombosis of dorsal wall ICA aneurysm died at 2 months with aneurysm recanalization with rerupture. Twenty-six patients achieved favorable outcome (GOS score 4 or 5) at last follow-up. The aneurysm recurrence rate using bare platinum coils of the same center was 11% and 7% for all aneurysms and ruptured aneurysms, respectively.

CONCLUSION

Matrix coil embolization was safe, but there was no reduction in aneurysm recurrence using matrix coils alone or mixed with GDCs, compared with GDCs alone.

摘要

背景

动脉瘤复发是使用弹簧圈进行动脉瘤血管内治疗的一个固有问题。一种名为Matrix(波士顿科学神经血管公司,加利福尼亚州弗里蒙特)的涂层弹簧圈系统,其表面覆盖有生物可吸收聚合材料(聚乙交酯/丙交酯共聚物[PGLA]),旨在加速瘤内血栓形成和纤维化。本研究的目的是评估Matrix可脱卸弹簧圈治疗颅内动脉瘤患者的疗效和安全性以及动脉瘤复发率。

方法

在香港的一个区域神经外科中心,收集了接受颅内动脉瘤血管内栓塞治疗患者的数据。在20个月的时间里,42例患者的44个动脉瘤接受了单独使用Matrix弹簧圈或与裸铂弹簧圈混合使用的血管内栓塞治疗。34例患者为破裂动脉瘤,8例患者为未破裂动脉瘤。

结果

25例患者(60%)进行了6个月的随访数字减影血管造影(DSA),10例患者(24%)进行了18个月的随访DSA。发现7例动脉瘤复发,所有动脉瘤的复发率为16%,破裂动脉瘤的复发率为14%。4例患者接受了重复栓塞治疗,2例患者接受了显微手术夹闭。记录到2例血栓栓塞引起的不良事件。一名78岁蛛网膜下腔出血分级较差的女性患者接受部分栓塞治疗后,在第4天死于再出血。另一名部分栓塞治疗且颈内动脉背壁动脉瘤自发血栓形成的患者在2个月时死亡,动脉瘤再通并再次破裂。26例患者在最后一次随访时获得了良好的结果(格拉斯哥预后评分4或5分)。同一中心使用裸铂弹簧圈时,所有动脉瘤和破裂动脉瘤的复发率分别为11%和7%。

结论

Matrix弹簧圈栓塞是安全的,但与单独使用GDC(普通弹簧圈)相比,单独使用Matrix弹簧圈或与GDC混合使用时,动脉瘤复发率并未降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验